These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9384711)

  • 41. Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer.
    Onsrud M; Shabana A; Austgulen R; Nustad K
    Gynecol Oncol; 1995 May; 57(2):183-7. PubMed ID: 7729731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
    Holler E; Kolb HJ; Hintermeier-Knabe R; Mittermüller J; Thierfelder S; Kaul M; Wilmanns W
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1234-6. PubMed ID: 8442099
    [No Abstract]   [Full Text] [Related]  

  • 43. [TNF-alpha in allogeneic bone marrow transplantation. Significance for immunologic reconstitution, acute graft versus host disease and risk of complications after bone marrow transplantation].
    Holler E
    Fortschr Med; 1991 Apr; 109(12):263-6. PubMed ID: 1855757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor-alpha associated with chronic graft-versus-host disease in bone marrow transplantation recipients.
    Fujii Y; Kaku K; Kaneko T
    Bone Marrow Transplant; 1992 Aug; 10(2):194-5. PubMed ID: 1525611
    [No Abstract]   [Full Text] [Related]  

  • 45. Increased cerebrospinal fluid levels of soluble receptors for tumour necrosis factor in HIV-infected patients with neurological diseases.
    Vullo V; Mastroianni CM; Lichtner M; Mengoni F; Delia S
    AIDS; 1995 Sep; 9(9):1099-100. PubMed ID: 8527085
    [No Abstract]   [Full Text] [Related]  

  • 46. [Relation of plasma soluble tumor necrosis factor receptor to tumor necrosis factor and clinical features of hepatitis B].
    Min WQ; Gu CH; Wang YM
    Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):602-4, 645-6. PubMed ID: 7842335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
    Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V
    Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis.
    Kornelisse RF; Savelkoul HF; Mulder PH; Suur MH; van der Straaten PJ; van der Heijden AJ; Sukhai RN; Hählen K; Neijens HJ; de Groot R
    J Infect Dis; 1996 Jun; 173(6):1498-502. PubMed ID: 8648229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphokines and the acute-phase response in clinical bone marrow transplantation.
    Cohen J; Bayston K
    Eur Cytokine Netw; 1990; 1(4):251-5. PubMed ID: 1716489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The relationship between plasma tumor necrosis factor alpha levels and complications after allogeneic bone marrow transplantation].
    Wan J; Huang X; Zheng H
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):625-7. PubMed ID: 11758246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pentoxifylline is not useful in the prevention of toxicity associated with bone marrow transplantation].
    López J; Cancelas JA; Valiño JM; García-Laraña J; Sastre JL; Pérez-Oteyza J; Cerveró C; García-Avello A; Cabezudo E; Arranz MI
    Med Clin (Barc); 1994 Apr; 102(13):485-8. PubMed ID: 8208006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
    Pilz G; Fraunberger P; Appel R; Kreuzer E; Werdan K; Walli A; Seidel D
    Crit Care Med; 1996 Apr; 24(4):596-600. PubMed ID: 8612409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prontera C; Facchini V; Genazzani A
    Oncol Rep; 1996 Sep; 3(5):891-4. PubMed ID: 21594476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of soluble tumor necrosis factor receptors after orthotopic liver transplantation.
    Kraus T; Mehrabi A; Arnold J; Wermann M; Klar E; Otto G; Herfarth C; Heilig B
    Transplant Proc; 1992 Dec; 24(6):2539-41. PubMed ID: 1334583
    [No Abstract]   [Full Text] [Related]  

  • 56. Allogeneic and autologous bone marrow transplant experiences in Hawaii.
    Wong LM; Jim RT; Loh KK; Wilkinson RW; Chong CD
    Hawaii Med J; 1994 Mar; 53(3):72-3, 84. PubMed ID: 7695682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever.
    Steinshamn S; Brekke OL; Waage A
    Br J Haematol; 1995 Apr; 89(4):719-24. PubMed ID: 7772508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.
    Vinante F; Rigo A; Tecchio C; Morosato L; Nadali G; Ricetti MM; Krampera M; Zanolin E; Locatelli F; Gallati H; Chilosi M; Pizzolo G
    Br J Haematol; 1998 Sep; 102(4):1025-34. PubMed ID: 9734654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
    Drenth JP; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk CG; van der Meer JW
    Blood; 1995 Jun; 85(12):3586-93. PubMed ID: 7780142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum markers of graft-versus-host disease after bone marrow transplantation.
    Kayaba H; Hirokawa M; Watanabe A; Saitoh N; Changhao C; Yamada Y; Honda K; Kobayashi Y; Urayama O; Chihara J
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 2):S40-4. PubMed ID: 10887332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.